CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $59.56 million. The enterprise value is $36.05 million.
| Market Cap | 59.56M |
| Enterprise Value | 36.05M |
Important Dates
The last earnings date was Thursday, April 4, 2024, before market open.
| Earnings Date | Apr 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 11.45 million shares outstanding.
| Shares Outstanding | 11.45M |
| Owned by Insiders (%) | 10.16% |
| Owned by Institutions (%) | 12.23% |
| Float | 7.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.55 |
| PS Ratio | 5.44 |
| Forward PS | 20.86 |
| PB Ratio | 2.10 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.62, with a Debt / Equity ratio of 0.11.
| Current Ratio | 8.62 |
| Quick Ratio | 8.33 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 15.24 |
Financial Efficiency
Return on equity (ROE) is -22.20% and return on invested capital (ROIC) is -23.85%.
| Return on Equity (ROE) | -22.20% |
| Return on Assets (ROA) | -18.80% |
| Return on Capital (ROIC) | -23.85% |
| Revenue Per Employee | $146,120 |
| Profits Per Employee | -$93,587 |
| Employee Count | 75 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.09% in the last 52 weeks. The beta is 0.41, so CLGN's price volatility has been lower than the market average.
| Beta (1Y) | 0.41 |
| 52-Week Price Change | -24.09% |
| 50-Day Moving Average | 5.24 |
| 200-Day Moving Average | 5.77 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (30 Days) | 7,680 |
Short Selling Information
| Short Interest | 10,828 |
| Short Previous Month | 8,112 |
| Short % of Shares Out | 0.14% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.29 |
Income Statement
In the last 12 months, CLGN had revenue of $10.96 million and -$7.02 million in losses. Loss per share was -$0.62.
| Revenue | 10.96M |
| Gross Profit | 8.97M |
| Operating Income | -7.51M |
| Pretax Income | -7.02M |
| Net Income | -7.02M |
| EBITDA | -6.41M |
| EBIT | -7.51M |
| Loss Per Share | -$0.62 |
Balance Sheet
The company has $26.67 million in cash and $3.16 million in debt, giving a net cash position of $23.52 million or $2.05 per share.
| Cash & Cash Equivalents | 26.67M |
| Total Debt | 3.16M |
| Net Cash | 23.52M |
| Net Cash Per Share | $2.05 |
| Equity / Book Value | 28.34M |
| Book Value Per Share | 2.47 |
| Working Capital | 24.77M |
Cash Flow
In the last 12 months, operating cash flow was -$2.76 million and capital expenditures -$886,000, giving a free cash flow of -$3.65 million.
| Operating Cash Flow | -2.76M |
| Capital Expenditures | -886,000 |
| Free Cash Flow | -3.65M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 81.83%, with operating and profit margins of -68.55% and -64.05%.
| Gross Margin | 81.83% |
| Operating Margin | -68.55% |
| Pretax Margin | -64.05% |
| Profit Margin | -64.05% |
| EBITDA Margin | -58.49% |
| EBIT Margin | -68.55% |
| FCF Margin | -33.30% |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.23% |
| Shareholder Yield | -3.23% |
| Earnings Yield | -11.78% |
| FCF Yield | -6.13% |
Analyst Forecast
The average price target for CLGN is $11.00, which is 111.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 111.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 2:3.
| Last Split Date | Nov 21, 2016 |
| Split Type | Reverse |
| Split Ratio | 2:3 |
Scores
CLGN has an Altman Z-Score of 2.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.67 |
| Piotroski F-Score | 3 |